Banff Automation System Improves Diagnosis of Kidney Allograft Rejection
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, May 15, 2023 -- The Banff Automation System, based on an algorithm covering all classification rules and diagnostic scenarios, can improve diagnosis of kidney allograft rejection, according to a study published online May 4 in Nature Medicine.
Daniel Yoo, from the Université Paris Cité and the Paris Institute for Transplantation and Organ Regeneration, and colleagues developed a decision-support system to improve diagnosis of kidney allograft rejection, based on an algorithm covering all classification rules and diagnostic scenarios. Its ability to reclassify diagnoses for adult and pediatric kidney transplant recipients in three international multicentric cohorts and two large prospective clinical trials, including 4,409 biopsies from 3,054 patients, was tested.
The researchers found that the Banff Automation System reclassified 29.75 percent of 279 antibody-mediated rejection cases and 54.29 percent of 105 T cell-mediated rejection cases in the adult kidney transplant population, and reclassified 7.32 percent of 3,239 biopsies diagnosed as nonrejection by pathologists as rejection. In the pediatric population, the reclassification rates were 30.77 percent of 26 and 30.77 percent of 39 for antibody- and T cell-mediated rejection, respectively. Reclassification of the initial diagnoses by the Banff Automation System was associated with improved risk stratification of long-term allograft outcomes.
"The results are unequivocal since more than 40 percent of diagnoses are corrected and reclassified by the machine," a coauthor said in a statement. "This tool will enable better patient care as well as improve clinical trials and the development of immunosuppressive treatments."
One author disclosed financial ties to Cibiltech, a software company not involved in the study.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Read this next
Heart Transplant Offer Acceptance Highest for White Women
TUESDAY, March 26, 2024 -- The cumulative incidence of heart transplant offer acceptance is highest for White women, according to a study published online March 25 in the Journal...
Metabolic, Bariatric Surgery Provides Pathway to Transplant in ESRD
TUESDAY, March 12, 2024 -- Referral of obese end-stage renal disease (ESRD) patients to metabolic and bariatric surgery (MBS) could offer a pathway to transplant, according to a...
No Improvement Noted in Black-White Kidney Transplant Rate Ratios
THURSDAY, Dec. 21, 2023 -- For patients with kidney failure, there appears to be no substantial improvement over time in the observed or adjusted Black-White mean living donor...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.